Unum plays its first glimpse of human data in an $86M IPO, revealing two deaths and an FDA hold
After promoting one of his top execs to president and bringing in two new board members, Unum Therapeutics CEO Chuck Wilson ended the week by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
